News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
Netflix Didn't Get Warner, But Chairman Reed Hastings Just Cashed Out $39.8 Million In Stock
Finviz·2026/03/05 18:42
Kohl's Stock Testing a Key Trendline Ahead of Earnings
Finviz·2026/03/05 18:42
Tenaya Therapeutics Stock Jumps After New Alnylam Deal
Finviz·2026/03/05 18:39
EWBC Posts Strong 2025 Revenues: Will the Growth Momentum Continue?
Finviz·2026/03/05 18:39
Strong AI Vision and End-Market Diversification Aids CGNX's Prospects
Finviz·2026/03/05 18:39
Canada: TD Securities on Economic Uncertainty and Trade Developments
101 finance·2026/03/05 18:39
Alt Dominance Signals Possible Third Altseason Breakout
Coinomedia·2026/03/05 18:39
Call for payment service providers to participate in digital euro pilot now open
101 finance·2026/03/05 18:39
Is purchasing Costco (COST) stock a smart move before the upcoming earnings report?
101 finance·2026/03/05 18:33
Is It Time to Rebalance Toward the United States? ETFs in Focus
Finviz·2026/03/05 18:33
Flash
22:12
All three major U.S. stock indexes closed lower, while U.S. cybersecurity stocks strengthened.格隆汇 March 6｜The three major US stock indexes closed down collectively, with the Dow Jones falling 1.61%, the S&P 500 index down 0.57%, and the Nasdaq down 0.26%. Major technology stocks were mixed, with Microsoft rising over 1%, Nvidia, Netflix, Amazon, and Intel posting slight gains; Meta fell over 1%, while Apple, Tesla, and Google saw slight declines. US cybersecurity stocks strengthened, with Okta up 11%, CrowdStrike up over 4%, and Datadog up over 3%.
22:08
Simon Property Group announces completion of amendments, restatements, and extensions to existing credit arrangementsThe latest maturity date for this financing instrument has been set for June 30, 2030. It is worth noting that the agreement includes an optional renewal clause, allowing the company to further extend the term to June 30, 2031.
22:07
According to the latest public documents from the U.S. Securities and Exchange Commission (SEC), biopharmaceutical company Contineum Therapeutics Inc. has launched a new stock offering plan.The company plans to publicly offer its Class A common stock through the underwriter Leerink Partners, with a maximum fundraising scale of up to 100 million USD. This financing plan aims to provide funding support for the company's clinical-stage research and development projects, further advancing the development process of its drugs for the treatment of neurological diseases. Specific issuance terms, including the offering price, number of shares, and final fundraising scale, will be determined based on market conditions.